Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data validation
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Public sources
Chapter 2 Executive Summary
2.1 Generative AI in healthcare industry 360º synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Application trends
2.1.4 End-use trends
Chapter 3 Generative AI in Healthcare Industry Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing demand for precision medicine and treatment
3.2.1.2 Increasing focus on enhancing medical imaging
3.2.1.3 Expanding advancement in AI
3.2.1.4 Increasing venture funding
3.2.2 Industry pitfalls & challenges
3.2.2.1 Data privacy and security concerns
3.2.2.2 Regulatory compliance
3.3 Growth potential analysis
3.3.1 By application
3.3.2 By end-use
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic dashboard, 2023
Chapter 5 Generative AI in Healthcare Market Estimates and Forecast, By Application, 2018-2032 (USD Million)
5.1 Key trends, by application
5.2 Personalized treatment
5.3 Patient assistance
5.4 Patient monitoring and predictive analytics
5.5 Medical image analysis and diagnostics
5.6 Drug discovery and development
5.7 Other applications
Chapter 6 Generative AI in Healthcare Market Estimates and Forecast, By End-use, 2018-2032 (USD Million)
6.1 Key trends, by end-use
6.2 Healthcare providers
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Diagnostic centers
6.2.4 Other healthcare providers
6.3 Pharmaceutical and life sciences companies
6.4 Healthcare payers
Chapter 7 Generative AI in Healthcare Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Rest of Latin America
7.6 Middle East & Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 Rest of Middle East & Africa
Chapter 8 Company Profiles
8.1 Epic Systems Corporation
8.2 DiagnaMed Holdings Corp.
8.3 Syntegra Medical Mind
8.4 IBM Watson Health Corporation
8.5 Google LLC
8.6 Oracle Corporation
8.7 Microsoft Corporation
8.8 Nvidia Corporation
8.9 Insilico Medicine
8.10 Abridge AI Inc.
8.11 ELEKS
8.12 Persistent Systems
